DEBBANE RAYMOND
SEC insider (Form 3/4/5 filer). CIK 0001053890. Director at LEXICON PHARMACEUTICALS, INC. (LXRX). 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in THE WOODLANDS, TX.
Companies DEBBANE RAYMOND has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Director
DEBBANE RAYMOND
CIK: 0001053890
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 3, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect89.3K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
35.7K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
43.5K shares- - Feb 25, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseDirect2K shares at avg. $1.49$3K - Feb 23, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseDirect100K shares at avg. $1.47$147K - Feb 20, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseDirect100K shares at avg. $1.48$148K - Feb 19, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseDirect50K shares at avg. $1.44$72K - Feb 18, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseDirect133.7K shares at avg. $1.32$176K - Feb 17, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseDirect76.9K shares at avg. $1.31$101K - Feb 13, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseDirect58K shares at avg. $1.31$76K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 89,312 | - | $0 | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 35,714 | - | - | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 43,478 | - | - | Direct |
| Feb 25, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 2,000 | $1.49 | $2,980 | Direct |
| Feb 23, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 100,000 | $1.47 | $147,000 | Direct |
| Feb 20, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 100,000 | $1.48 | $147,790 | Direct |
| Feb 19, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 50,000 | $1.44 | $71,965 | Direct |
| Feb 18, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 133,688 | $1.32 | $176,468 | Direct |
| Feb 17, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 76,857 | $1.31 | $100,544 | Direct |
| Feb 13, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 57,952 | $1.31 | $75,877 | Direct |
1-10 of 13 transactions